Wednesday, 04. February 2026 Share: YouTube RSS

Lilly says Mounjaro and Zepbound sales grew by at least 110% as stock rallies

The drugmaker also detailed strong growth for 2026

Source: MarketWatch

Continue reading...

Related Articles

×